Bibliographical noteFunding Information:
This study is supported by the National Institute for Health Research (NIHR) University College London Hospitals NHS Foundation Trust (UCLH) Biomedical Research Centre and Blood Cancer UK. Robert S. Heyderman is a NIHR Senior Investigator. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
- B-cell malignancy